U.S. Intrauterine Devices Market Size, Share, Trend & Growth Forecast to 2024: Major Vendors Bayer, Teva Pharmaceutical

The U.S intrauterine devices market is estimated to amass substantial returns in the ensuing years owing to the country’s growing teen pregnancy rates along with the device’s increasing adoption by the female populace in the U.S.

As per data released by the U.S Department of Health and Human Services, 209,809 babies were born to women who were between the age of 15 to 19, accounting for 5.3 percent of all births in the region in 2016. Although teen pregnancy rates have declined in recent years the United States still ranks higher than many other developed nations, including the UK and Canada.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1251695/

According to Guttmacher Institute, 75% of pregnancies occurring in individuals between 15 to 19 years of age are unplanned. The institute also claims that pregnancy rates among teens would have been up by 73% without publicly funded family planning initiatives. IUDs have been proven to be highly effective and have a low failure rate compared to other birth control measures, which is more likely to help in preventing teen pregnancies, thereby driving the growth of the intrauterine devices market in the US.

East North Central zone accounted for USD 177.2 million sales of intrauterine device in the year 2017. High teenage pregnancies in the region will favor the adoption of IUD among the women aged 15 to 19 years of age. As per the reports published by Centers for Disease Control and Prevention (CDC), the teen birth rate in Iowa state in 2014 was around 20 per 1000 women. Also, activities such as Medicaid Family Planning Waiver/State Plan Amendment in the region will foster the growth of intrauterine device market.

Increase in number of women in U.S. opting for planned delayed pregnancy will result in high intrauterine device usage, fueling the IUD market growth. According to the Pew Research Center, the mothers in the U.S. are estimated to be older than 35 years of age. Number of women delay marriage and pregnancy to seek higher education and establish their careers. Also, recent technological advancements in fertility technology prompts women to use reversible contraceptive methods such as intrauterine device, impacting the business growth.

Hormonal intrauterine device are estimated to show substantial growth at a CAGR of 8.2% over the forecast timeframe. Hormonal IUDs provide effective protection against unwanted pregnancy and pose very less risk to the user. The increase in inclination of women in the country towards hormonal contraception will boost the U.S. intrauterine device market growth over the future.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1251695/

Variability in insurance coverage and access will be one of the major market restraining factors. The women with no insurance coverage or with private insurance face high upfront costs that can exceed up to more than thousand dollars. Hence, variability in insurance coverage will decline the number of users impeding the market growth.

Sales of intrauterine device in Pacific Central zone is estimated to grow at a CAGR of 7.6% during the foreseeable future. Honolulu Health Center in Hawaii offers education on birth control and usage of contraceptive methods to the teenage girls in order to prevent teenage pregnancies. The rise in awareness will increase the number of women opting for effective reversible contraceptive such as intrauterine devices.

The notable industry players are Bayer AG and Teva Pharmaceutical. Industry players are focusing on strengthening their research and development activities by launching technologically improved and enhanced intrauterine device along with adopting strategies such as partnership, strategic collaboration, acquisition and merger to enhance their business.

Table of Content:

Chapter 2. Executive Summary
2.1. U.S. Intrauterine Devices industry 360 degree synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Age Group trends
2.1.4. Regional trends

Chapter 3. U.S. Intrauterine Devices Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Favorable regulatory scenario
3.3.1.2. Rising awareness among U.S. women regarding various IUD applications
3.3.1.3. High number of unintended pregnancies
3.3.1.4. Government initiatives for the prevention of unwanted abortions and pregnancies
3.3.1.5. Growing inclination towards planned delayed pregnancy
3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost of device
3.3.2.2. Risk of several health issues
3.3.2.3. Variability in insurance coverage and access
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By age group
3.5. Porter's analysis
3.6. Competitive landscape, 2017
3.6.1. Business overview
3.6.2. Revenue analysis
3.6.3. Product landscape
3.6.4. Strategy dashboard
3.7. PESTEL analysis

Chapter 4. U.S. Intrauterine Devices Market, By Product
4.1. U.S. Intrauterine Devices Market share, by product, 2017 & 2024
4.2. Copper Intrauterine Devices
4.2.1. Market estimates and forecast, by region, 2013 - 2024
4.3. Hormonal Intrauterine Devices
4.3.1. Market estimates and forecast, by region, 2013 - 2024

Chapter 5. U.S. Intrauterine Devices Market, By Age Group
5.1. U.S. Intrauterine Devices Market share, by age group, 2017 & 2024

Outer scope of this report intrauterine devices have been gaining trust among majority of women in the U.S. According to a report by the National Center for Health Statistics, sterilization turned out to be the most commonly used contraceptive method, utilized by nearly 47 million women between the age group 15 and 49. The report further stated that around 19% of women relied on female sterilization methods including permanent sealing, cutting, blocking or tying of the fallopian tubes. Besides birth control pills, around 10% of women have used long-lasting reversible contraceptives like intrauterine devices. Well-established factors like trust and longevity of the method are likely to augment the U.S intrauterine devices market in the coming years.

For more information on this report at: https://www.marketstudyreport.com/reports/u-s-intrauterine-devices-market/?utm_source=OPR-SP

Related Report:

Global Intrauterine Devices Market Research Report 2018

This report studies the global Intrauterine Devices market status and forecast, categorizes the global Intrauterine Devices market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

https://www.marketstudyreport.com/reports/global-intrauterine-devices-market-research-report-2018/?utm_source=RR-SP

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

This release was published on openPR.